Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Copay Charity Assistance Advisory Rescinded Over Patient Steering Concerns

Executive Summary

US OIG's first-ever rescission means the advisory is revoked retroactively to its date of issue, which could lead to anti-kickback enforcement actions against behavior by the charity and manufacturer donors since then. 

You may also be interested in...



Pfizer Agrees To Oversight Of Charitable Assistance Programs In DOJ Settlement

Second pharma charity kickback settlement in six months resolves claims Pfizer used charity to pay Medicare patient copays for three drugs.

Drug Donations Still Allowed After Copay Charity Suspends Operations

OIG tells PhRMA that Medicare patients can receive free drugs after Caring Voice Coalition's safe harbor was rescinded as long as sponsors follow certain conditions.

Copay Kickback Enforcement Gains Momentum: United Therapeutics Settles Charges

Settlement is first involving a copay assistance program operated through Caring Voice Coalition since the HHS Office of Inspector General rescinded a safe harbor for the charity's activities in late November. Is it the first of a wave?

Related Content

Topics

UsernamePublicRestriction

Register

PS122057

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel